Diabetes care stocks
Heavily traded in Diabetes care
Turnover over $10M/day6 of about 20 companies in this theme turn over more than $10M in a typical session. Largest market value first. Data as of Sep 15, 2026.
| Company | Turnover | 1Y return | Next report |
|---|---|---|---|
| DXCMDexCom, Inc. | $343.77M | +12.04% | Oct 29, 2026 |
| PODDInsulet Corporation | $180.73M | −59.51% | Nov 5, 2026 |
| MNKDMannKind Corporation | $14.44M | −30.30% | Nov 4, 2026 |
| TNDMTandem Diabetes Care, Inc. | $28.34M | +39.04% | Nov 5, 2026 |
| 6523.TPHC Holdings Corporation | $526.61M | +33.32% | Nov 11, 2026 |
| BBNXBeta Bionics, Inc. | $15.98M | −33.90% | Oct 27, 2026 |
Turnover is the median value traded in one session, measured over the past 50 sessions. It describes trading activity in a stock and nothing about the company behind it.
Table
23 companies, largest market value first.
Data as of Sep 15, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| DXCM | DexCom, Inc. | $31.95B | Large cap | +12.04% |
| D1EX34.SA | DexCom, Inc. | $31.86B | Large cap | +6.50% |
| PODD | Insulet Corporation | $9.56B | Mid cap | −59.51% |
| MNKD | MannKind Corporation | $1.21B | Small cap | −30.30% |
| TNDM | Tandem Diabetes Care, Inc. | $1.17B | Small cap | +39.04% |
| 6523.T | PHC Holdings Corporation | $1.06B | Small cap | +33.32% |
| BBNX | Beta Bionics, Inc. | $752.68M | Small cap | −33.90% |
| SENS | Senseonics Holdings, Inc. | $467.41M | Small cap | −2.21% |
| SABS | SAB Biotherapeutics, Inc. | $314.81M | Small cap | +64.76% |
| EMBC | Embecta Corp. | $296.90M | Small cap | −64.29% |
| ORMP | Oramed Pharmaceuticals Inc. | $191.12M | Small cap | +115.92% |
| BIOM3.SA | Biomm S.A. | $173.66M | Small cap | −20.94% |
| BMEA | Biomea Fusion, Inc. | $129.02M | Small cap | −9.18% |
| VTVT | vTv Therapeutics Inc. | $124.31M | Small cap | +54.04% |
| ADOC.PA | Adocia SA | $82.71M | Micro cap | −53.76% |
| T2ND34.SA | Tandem Diabetes Care, Inc. | $79.68M | Micro cap | +13.93% |
| AREC.L | Arecor Therapeutics plc | $41.27M | Micro cap | +11.72% |
| MODD | Modular Medical, Inc. | $21.03M | Micro cap | −88.50% |
| DMYD-B.ST | Diamyd Medical AB (publ) | $16.13M | Micro cap | −90.77% |
| POXEL.PA | Poxel S.A. | $12.75M | Micro cap | −42.73% |
| TRIB | Trinity Biotech plc | $6.07M | Micro cap | +527.73% |
| LABT | Lakewood-Amedex Biotherapeutics, Inc. | $5.02M | Micro cap | −75.49% |
| GCTK | GlucoTrack, Inc. | $1.96M | Micro cap | −68.51% |
Covers ~23,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Price and the 52-week distance are in the currency the stock trades in; only market values are converted.
We cover 23 companies grouped under the Diabetes care theme. The median market value in the group is $173.66M. Across the group, the median move over the past trading day is +0.21%. 48% of the 21 with a 200-day average trade above it. Price change over the past year runs from −74.1% to +62.6% across the middle 80 percent of the group, with a median of −9.2%.